Cite

HARVARD Citation

    Marchetti, A. et al. (2021). An up-to-date evaluation of cabozantinib for the treatment of renal cell carcinoma. Expert opinion on pharmacotherapy. pp. 2323-2336. [Online]. 
  
Back to record